AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

They could perhaps see sustained runs beyond this year.

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...

The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the ...

Global investors in AI, machine learning, semiconductors, biotech, and data infrastructure face intersecting regulatory risks that affect talent, supply chains, governance, and exits. Those who ...

In this article, we will take a look at 9 Oversold Biotech Stocks to Invest In. Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value ...

SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...